|Archives| Charts| Companies/Links| Conferences| How A Fuel Cell Works | Patents|
| Types of Fuel Cells | The Basics | Fuel Cell News | Basics on Hydrogen | Search|
 
*Stay Updated every week With a Free Subscription To "Inside The Industry"As Well as a Weekly Updated Patents Page
 
   Medis Technologies Announces Purchase Agreement for $38 Million Senior Convertible Notes

Publication Date:24-July-2005
03:25 PM US Eastern Timezone 
Source:Medis Technologies
 
NEW YORK-- Medis Technologies Ltd. (MDTL) today announced that it has signed a definitive purchase agreement for the offering and sale of $38 million aggregate principal amount of 6% Senior Convertible Notes due 2010, exclusive of an option granted to the initial purchaser to purchase and sell an additional $7 million aggregate principal amount of notes for a thirty-day period following the date of the offering memorandum relating to the offering, for a total of up to $45 million aggregate principal amount of notes. The net proceeds will be used for the construction, start-up and other costs related to a fully-automated manufacturing line for the Company's fuel cell products as well as for working capital and general corporate purposes. 

The offering constituting a private placement under Rule 144A of the Securities Act of 1933 only to qualified institutional buyers. The securities will not be registered under the Securities Act and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security and shall not constitute an offer, solicitation or sale of any securities in any jurisdiction in which such offering sold would be unlawful. 

This press release may contain forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve risk and uncertainties, including, but not limited to, the successful completion of product development, the success of product tests, commercialization risks, availability of financing and results of financing efforts. Further information regarding these and other risks is described from time to time in the Company's filings with the SEC.
 
 

~

 
© 1999 - 2005 FuelCellWorks.com All Rights Reserved.
1setstats1setstats11
setstats1setstatssetstatssetstatssetstatssetstats1setstatssetstatssetstatssetstats1setstats1setstats1setstats1setstats1setstats1setstats1setstats1setstats1setstats1setstats1setstats1setstats1setstats1setstats1setstats1